High Fat Diet Accelerates Pathogenesis of Murine Crohn's Disease-Like Ileitis Independently of Obesity

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Gruber, Lisa ^a   Kisling, Sigrid ^a   Lichti, Pia ^a   Martin, François Pierre ^b,c   May, Stephanie ^a   Klingenspor, Martin ^a   Lichtenegger, Martina ^a   Rychlik, Michael ^a   Haller, Dirk ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GLUCOSE; MACROGOL; OCCLUDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CROHN DISEASE LIKE ILEITIS; DENDRITIC CELL; ENDOTOXEMIA; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HISTOPATHOLOGY; ILEITIS; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; LAMINA PROPRIA; LIPID DIET; LYMPHOCYTIC INFILTRATION; MESENTERIC TISSUE CHARACTERISTIC; MOUSE; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN EXPRESSION; TH17 CELL; TISSUE CHARACTERIZATION;

ADIPOSE TISSUE; ANIMALS; CELL POLARITY; CROHN DISEASE; DENDRITIC CELLS; DIET, HIGH-FAT; ENDOTOXINS; ENTEROCYTES; GENE EXPRESSION REGULATION; GLUCOSE; ILEITIS; ILEUM; INFLAMMATION; MICE; MICE, INBRED C57BL; MUTATION; OBESITY; OCCLUDIN; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84882629237     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071661     Document Type: Article

References (34)

1. Hass DJ, Brensinger CM, Lewis JD, Lichtenstein GR, (2006) The impact of increased body mass index on the clinical course of Crohn's disease. Clin Gastroenterol Hepatol 4: 482-488.
2. Long MD, Crandall WV, Leibowitz IH, Duffy L, del Rosario F, et al. (2011) Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis 17: 2162-2168.
3. Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre JP, et al. (2002) Crohn's disease clinical course and severity in obese patients. Clin Nutr 21: 51-57.
4. Hou JK, Abraham B, El-Serag H, (2011) Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 106: 563-573.
5. Ding S, Chi MM, Scull BP, Rigby R, Schwerbrock NM, et al. (2010) High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS One 5: e12191.
6. Lam YY, Ha CW, Campbell CR, Mitchell AJ, Dinudom A, et al. (2012) Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One 7: e34233.
7. Stenman LK, Holma R, Gylling H, Korpela R (2013) Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity. Br J Nutr: 1-8.
8. Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, et al. (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292: G518-525.
9. Suzuki T, Hara H, (2010) Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond) 7: 19.
10. Strober W, Fuss IJ, (2011) Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140: 1756-1767.
11. Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, et al. (2010) The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis 4: 7-27.
12. Apostolaki M, Manoloukos M, Roulis M, Wurbel MA, Muller W, et al. (2008) Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease. Gastroenterology 134: 2025-2035.
13. Baur P, Martin FP, Gruber L, Bosco N, Brahmbhatt V, et al. (2011) Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(DeltaARE/WT) mouse model. J Proteome Res 10: 5523-5535.
14. Cooper HS, Murthy SN, Shah RS, Sedergran DJ, (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69: 238-249.
15. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, et al. (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115: 695-702.
16. Ruiz PA, Shkoda A, Kim SC, Sartor RB, Haller D, (2006) IL-10 gene-deficient mice lack TGF-beta/Smad-mediated TLR2 degradation and fail to inhibit proinflammatory gene expression in intestinal epithelial cells under conditions of chronic inflammation. Ann N Y Acad Sci 1072: 389-394.
17. Chang JS, Ocvirk S, Berger E, Kisling S, Binder U, et al. (2012) Endoplasmic reticulum stress response promotes cytotoxic phenotype of CD8alphabeta+ intraepithelial lymphocytes in a mouse model for Crohn's disease-like ileitis. J Immunol 189: 1510-1520.
18. Vidal K, Grosjean I, evillard JP, Gespach C, Kaiserlian D, (1993) Immortalization of mouse intestinal epithelial cells by the SV40-large T gene. Phenotypic and immune characterization of the MODE-K cell line. J Immunol Methods 166: 63-73.
19. Kaiserlian D, Vidal K, (1993) Antigen presentation by intestinal epithelial cells. Immunol Today 14: 144.
20. Doerrler W, Feingold KR, Grunfeld C, (1994) Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms. Cytokine 6: 478-484.
21. Green A, Dobias SB, Walters DJ, Brasier AR, (1994) Tumor necrosis factor increases the rate of lipolysis in primary cultures of adipocytes without altering levels of hormone-sensitive lipase. Endocrinology 134: 2581-2588.
22. Chan SS, Luben R, Olsen A, Tjonneland A, Kaaks R, et al. (2013) Body Mass Index and the Risk for Crohn's Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The IBD in EPIC Study). Am J Gastroenterol 108: 575-582.
23. Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, et al. (2012) Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 487: 104-108.
24. Kim KA, Gu W, Lee IA, Joh EH, Kim DH, (2012) High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway. PLoS One 7: e47713.
25. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481.
26. Dieu-Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, et al. (2000) Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 192: 705-718.
27. Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, et al. (2004) Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol 24: 74-85.
28. Puleston J, Cooper M, Murch S, Bid K, Makh S, et al. (2005) A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther 21: 109-120.
29. Cayatte C, Joyce-Shaikh B, Vega F, Boniface K, Grein J, et al. (2012) Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease. Clin Transl Gastroenterol 3: e10.
30. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119-124.
31. Katchar K, Kelly CP, Keates S, O'Brien M J, Keates AC, (2007) MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice. Am J Physiol Gastrointest Liver Physiol 292: G1263-1271.
32. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, et al. (2007) Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204: 2803-2812.
33. Wang C, Kang SG, Lee J, Sun Z, Kim CH, (2009) The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol 2: 173-183.
34. Winer S, Paltser G, Chan Y, Tsui H, Engleman E, et al. (2009) Obesity predisposes to Th17 bias. Eur J Immunol 39: 2629-2635.